2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$9.86+$0.17 (+1.75%)
Price as of Aug 03, 2026 7:07 AM EDT- $620.4MMarket Cap
- 18.32%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$9.86+$0.17 (+1.75%)
RGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.69 | ||
Change | -$0.43 (-4.25%) | ||
Open | $10.25 | ||
High | $10.38 | ||
Low | $9.63 | ||
Previous Close | $10.12 | ||
Volume | 1,157,484 | ||
30-Day Average Volume | 2,262,238 | ||
1-Week Change | -0.41% | ||
1-Month Change | -19.12% | ||
1-Year Change | 18.32% | ||
3-Year Change | -49.00% | ||
5-Year Change | -70.02% | ||
Fundamentals | |||
Shares Outstanding | 64.0M | ||
Total Assets | $341.9M | ||
Market Cap | $620.4M | ||
Enterprise Value | $605.1M | ||
Period: QTR TTM FY | |||
Revenue | $5.1M | ||
Net Income | -$90.1M | ||
Free Cash Flow | -$77.4M | ||
EBIT | $102.4M | ||
EBITDA | $106.3M | ||
Net Working Capital | $115.4M | ||
EPS | -$1.72 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | 119 | ||
P/B | 29 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue